CARDIOVASCULAR SENSITIVITY CHANGES TO EICOSANOIDS IN RATS WITH EXPERIMENTALLY INDUCED DIABETES MELLITUS
- 1 January 1992
- journal article
- review article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 19 (1) , 9-15
- https://doi.org/10.1111/j.1440-1681.1992.tb00391.x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Changes in cardiovascular sensitivity of alloxan-treated diabetic rats to arachidonic acidBritish Journal of Pharmacology, 1986
- Glutathione redox state is not the link between polyol pathway activity and myo-inositol-related Na+-K+-ATPase defect in experimental diabetic neuropathyDiabetes, 1986
- The positive inotropic effect of sodium arachidonate on auricles from diabetic ratsEuropean Journal of Pharmacology, 1985
- INHIBITION OF THROMBOXANE SYNTHETASE DOES NOT NECESSARILY PREVENT PLATELET AGGREGATIONThe Lancet, 1981
- Decreased vascular prostacyclin (PGI2) in diabetic rats. Stimulation of PGI2 release in normal and diabetic rats by the antithrombotic compound bay g 6575Thrombosis Research, 1980
- Thromboxane production and platelet aggregation in diabetic subjects with clinical complicationsThrombosis Research, 1980
- CIRCULATING PROSTACYCLIN MAY BE REDUCED IN DIABETESThe Lancet, 1979
- PROSTACYCLIN AND THROMBOXANE METABOLITES IN DIABETESThe Lancet, 1979
- Vascular Reactivity in Experimental Diabetes MellitusCirculation Research, 1964
- EXPERIMENTAL ALLOXAN DIABETES IN THE RATThe Lancet, 1943